Zepbound Near Me: Clinics, Pharmacies and Telehealth by State

Any US pharmacy can fill a Zepbound prescription; ask your local pharmacy to order it if it is not on the shelf. The lowest self-pay price is $299 a month, and the lowest pharmacy cash price we found is $299 a month at Walmart Pharmacy.

Lowest self-pay: $299 a month
Telehealth from, all in: $373 a month
Prescription: RequiredFDA label (DailyMed)
Shortage: Resolved

Zepbound overview

How long the drug stays in your body

The half-life is 5 to 6 days. At 5.5 d, half is gone. About 3% remains after five half-lives (27.5 d).

How much weight was lost in its main trial

In SURMOUNT-1 over 72 weeks, body weight fell 20.9% versus 3.1% with placebo.

Prices over time

The monthly price points, stated in US dollars, are the list price and self-pay offers. Each figure comes from the maker's price page.

Sources: FDA label (DailyMed), Eli Lilly 1 2, cnbc.com.

All legitimate ways to get Zepbound, ranked

Ways to get it, listed from cheapest to highest
Route	Who it is for	What you pay
Your doctor, with insurance and the savings card	Commercial insurance that covers it	For as little as $25, you can get up to a 3-month fill
LillyDirect: LillyDirect vial or KwikPen 2.5 mg	Anyone with a prescription, no insurance needed	$299 a month
TrumpRx listing (vial, starting)	Self-pay only	$299 a month
Walmart Pharmacy: LillyDirect self-pay (lowest dose)	Cash at the pharmacy counter	$299 a month
Telehealth: WeightWatchers Med+, Zepbound (self-pay)	Online visit, medicine shipped	$373 a month all in

Prices checked November 2026. Each price links to its source page.

Sources: pricinginfo.lilly.com, zepbound.lilly.com, Eli Lilly, TrumpRx.

Who qualifies

A prescription is required for every GLP-1 sold in the US. A prescriber writes it for an approved use on the label:

Diet and activity can help adults with obesity, or who are overweight with a weight-related condition, lose weight and keep it off long term.
Moderate to severe obstructive sleep apnea in adults with obesity is what it treats.

The FDA label (DailyMed) is required

Telehealth choices compared

Telehealth programs for Zepbound
Program	Medicine option	Medicine price	Membership	All in
WeightWatchers Med+	Zepbound (self-pay)	$299 a month	$74 a month	$373 a month
Ro	Zepbound KwikPen, starting dose	$299 a month	$149 a month	$448 a month
Hims & Hers	Zepbound	$1,899 a month	$149 a month after first month	$2,048 a month

Each program's prices come from its own pricing page. We do not make money from any of them

Sources: weightwatchers.com, ro.co, hims.com.

Current Shortage status

Tirzepatide: Shortage resolved. The FDA made that confirmation on December 19, 2024.

The FDA shortage list first included it on December 15, 2022
Shortage resolved: December 19, 2024
State pharmacies could no longer compound copies: February 18, 2025
Outsourcing facilities had to stop as of March 19, 2025

Source: FDA.

Scam signals

A prescription is not needed: sellers who skip it cannot be licensed pharmacies in the US.
A brand price well below the manufacturer's own: the lowest self-pay cost for the brand is $299 a month
If a seller calls it the brand but compounds it, compounded versions have no FDA approval and are not Ozempic, Wegovy, Mounjaro or Zepbound.
Telehealth companies said it was the same as the brand, so the FDA sent 30 warning letters about misleading claims.
For compounded tirzepatide, the FDA has more than 730 adverse event reports.
The FTC acted against one program for omitting the drug from its monthly price; see the NextMed review for details.

Sources: pricinginfo.lilly.com, zepbound.lilly.com, Eli Lilly, TrumpRx.

Where you can find it in your state

Some of the 50 states are not served by Hims & Hers
Across the 50 states, Noom Med does not reach every one
The NovoCare Pharmacy delivery network covers all 50 states, DC, Puerto Rico

Your route is affected most by Medicaid rules. right now, 10 state Medicaid programs cover GLP-1s used for weight loss. Select your state to view its drug list and the rules for prior authorization:

Sources: hims.com, noom.com, NovoCare.